Abstract:Background: Calcific aortic valve disease (CAVD) is one of the most frequently occurring valvular heart diseases among the aging population. Currently, there is no known pharmacological treatment available to delay or reverse CAVD progression. The regulation of gene expression could contribute to the initiation, progression, and treatment of CAVD. Non-coding RNAs (ncRNAs) and transcription factors play essential regulatory roles in gene expression in CAVD; thus, further research is urgently needed. Materials and Methods: The gene-expression profiles of GSE51472 and GSE12644 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) were identified in each dataset. A protein-protein-interaction (PPI) network of DEGs was then constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins database, and functional modules were analyzed with ClusterOne plugin in Cytoscape. Furthermore, Gene Ontology-functional annotation and Kyoto Encyclopedia of Genes and Genomes-pathway analysis were conducted for each functional module. Most crucially, ncRNAs and transcription factors acting on each functional module were separately identified using the RNAInter and TRRUST databases. The expression of predicted transcription factors and key genes was validated using GSE51472 and GSE12644. Furthermore, quantitative real-time PCR (qRT-PCR) experiments were performed to validate the differential expression of most promising candidates in human CAVD and control samples. Results: Among 552 DEGs, 383 were upregulated and 169 were downregulated. In the PPI network, 15 functional modules involving 182 genes and proteins were identified. After hypergeometric testing, 45 ncRNAs and 33 transcription factors were obtained. Among the predicted transcription factors, CIITA, HIF1A, JUN, POU2F2, and STAT6 were differentially expressed in both the training and validation sets. In addition, we found that key genes, namely, CD2, CD86, CXCL8, FCGR3B, GZMB, ITGB2, LY86, MMP9, PPBP , and TYROBP were also differentially expressed in both the training and validation sets. Among the most promising candidates, differential expressions of ETS1, JUN, NFKB1, RELA, SP1, STAT1, ANCR, and LOC101927497 were identified via qRT-PCR experiments. Conclusion: In this study, we identified functional modules with ncRNAs and transcription factors involved in CAVD pathogenesis. The current results suggest candidate molecules for further research on CAVD.

Effects of Overexpression of CRELD1 Gene on Heart Valve-Related Matrix Proteins

Identification of Key Genes in Calcific Aortic Valve Disease by Integrated Bioinformatics Analysis.

[Potential Role of CRELD1 Gene in the Pathogenesis of Atrioventricular Septal Defect].

Novel CRELD1 gene mutations in patients with atrioventricular septal defect

Analysis of CRELD1 gene mutations in Han Chinese patients with atrioventricular septal defect

Effect of Cellular Repressor of E1A Stimulated Genes (CREG1) on Cardiac Function Injury Induced by Angiotensin Ⅱ in Mice

[Effects of Overexpression of Decorin on Matrix Metalloproteinases 2 and 9 in Rat Mesangial and Tubular Cells].

Creld1 regulates myocardial development and function

Experimental Studies on the Role of GATA4 in the Endocardial Cushions Development

Expression of PCPE-1 Mrna in Murine Dilated Cardiomyopathy Induced by Aldosterone

Abstract 230: Cartilage Intermediate Layer Protein-1 Attenuates Pressure Overload-induced Cardiac Fibrosis by Targeting Transforming Growth Factor-β1

Effect of cellular repressor protein of E1A-stimulated genes on the apoptosis of human umbilical vein endothelial cells

Decreased expression of RPL15 and RPL18 exacerbated the calcification of valve interstitial cells during aortic valve calcification

Abstract P1026: Creg1 Inhibits Cardiomyocyte Proliferation And Promotes Myocardial Differentiation And Compaction During Postnatal Cardiac Development

Deciphering transcriptional dynamics of cardiac hypertrophy and failure in a chamber-specific manner

GW24-e1273 Transplantation of Cellular Repressor of E1A-stimulated Gene Modified Embryonic Stem Cells Improves Heart Function Post-Myocardial Infarction Through Blocking MAPK-ERK1/2 Pathway

Screening of Molecular Biomarkers Associated with Heart Failure Derived from Arrhythmogenic Right Ventricular Cardiomyopathy

Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease

Effects of COL1A1 and SYTL2 on inflammatory cell infiltration and poor extracellular matrix remodeling of the vascular wall in thoracic aortic aneurysm

Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

Hvegf165/pcdna3.1 Expression in Neonate Mice Myocardial Cells